Dean Y. Li - Director at Recursion Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
RXRX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Dean Y. Li since 4/22/2024

Holdings reported by Dean Y. Li for Recursion Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Class A Common Stock 1.42M $8.59M $6.04 Apr 1, 2025 By Dean Li and Ruth Li Revocable Trust
Class A Common Stock 1.27M $7.67M $6.04 Apr 1, 2025 By Dean Y. Li GRAT
Class A Common Stock 421K $2.54M $6.04 Apr 1, 2025 By Dean Y. Li 2021 Family Trust
Class A Common Stock 79.6K $481K $6.04 Apr 1, 2025 Direct
Stock Option (Right to Buy) 26.2K Jun 3, 2024 Direct Class A Common Stock

Transactions reported by Dean Y. Li for Recursion Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.